FDA Releases New Tools to Speed COVID-19 Test Development
Executive Summary
The US agency on 29 May gave two additional tools to COVID-19 test developers: an emergency use authorization template for tests using at-home sample collection kits, and a reference panel for the disease.
You may also be interested in...
FDA Releases COVID-19 Test Performance Data
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.
FDA Authorizes First At-Home COVID-19 Saliva Sample Collection Kit
The US agency has authorized the first COVID-19 test to use at-home saliva sample collection. Rutgers Clinical Genomics Laboratory landed the emergency use authorization.
App Developers Turning To HIPAA Compliance In Face Of Growing State Data Privacy Constraints
Manufacturers faced with an increasingly complex landscape of state patient-privacy laws may opt to comply with federal Health Insurance Portability and Accountability Act regulations instead, attorney Brad Rostolsky tells Medtech Insight.